ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution
Shinsuke Oshima(Astellas Pharma (Japan)), Yasuyuki Higashi(Kobe Institute Of Computing)
Cited by 7
Related Papers
No related papers found
Powered by citation graph analysis